Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03964233
Title A Study in Patients With Different Types of Advanced Cancer (Solid Tumors) to Test Different Doses of BI 907828 in Combination With BI 754091 (Ezabenlimab) and 754111 or BI 907828 in Combination With BI 754091 (Ezabenlimab)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Boehringer Ingelheim
Indications

lung non-small cell carcinoma

melanoma

hepatocellular carcinoma

Advanced Solid Tumor

liposarcoma

Therapies

BI 754091 + BI 754111 + BI 907828

BI 754091 + BI 907828

BI 907828

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST